Pediatrics Doctors in Bessemer, AL Accepting Medicare

14 Pediatrics doctors found. Showing 1 - 14

Dr. Charles W. Schlappi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1090 9th Ave Sw Ste 100, Bessemer, AL 35022 Phone: 205-481-1886    Fax: 205-481-9034

Tracy Brookings, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4730 Bell Hill Rd, Bessemer, AL 35022 Phone: 205-426-3010    Fax: 205-481-9034

Bassam Babi, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6250 Park South Dr, Bessemer, AL 35022 Phone: 205-425-5440    Fax: 205-425-5513

Dr. Delsadie Pullar Callins, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2201 Arlington Ave, Bessemer, AL 35020 Phone: 205-424-6001    Fax: 205-497-9369

Margaret Elaine Wester, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4730 Bell Hill Rd, Bessemer, AL 35022 Phone: 205-426-3010    Fax: 205-481-9034

Joni Mitchell Gill, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2201 Arlington Ave, Bessemer, AL 35020 Phone: 205-424-6001    Fax: 205-497-9369

Mekeisha Renae Pickens, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1090 9th Ave Sw, Suite 100, Bessemer, AL 35022 Phone: 205-481-1886    Fax: 205-481-9034

Dr. Iris Denise Fancher, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2201 Arlington Ave, Bessemer, AL 35020 Phone: 205-424-6001    Fax: 205-497-9369

Abby Morris Allen, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1090 9th Ave Sw, Suite 100, Bessemer, AL 35022 Phone: 205-481-1886

Dr. Charlotte Margot Prejean, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4730 Bell Hill Rd, Bessemer, AL 35022 Phone: 205-426-3010    Fax: 205-481-9034

Dr. Marwan S Shalabi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 6250 Park South Dr, Bessemer, AL 35022 Phone: 205-425-5440    Fax: 205-425-5513

Hubert Alfredo Rodriguez, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1090 9th Ave Sw, Suite 100, Bessemer, AL 35022 Phone: 205-481-1886    Fax: 205-481-9034

Dr. Hoyt Thomas Smith Jr., M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1090 9th Ave Sw, Suite 100, Bessemer, AL 35022 Phone: 205-481-1886    Fax: 205-481-9034

Dr. Janet Chandler Harris, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1090 9th Ave Sw, Suite 100, Bessemer, AL 35022 Phone: 205-481-1886    Fax: 205-481-9034

News Archive

Urocidin Phase III non-muscle-invasive bladder cancer trial interim results to be presented at EAU, AUA conferences

Endo Pharmaceuticals and Bioniche Life Sciences Inc. today announced plans for peer-reviewed presentation of interim efficacy and safety results from the first Phase III trial of the intravesical formulation of Mycobacterial cell wall-DNA complex (MCC), known as Urocidin™ or EN3348.

Psychoticism, immature defense mechanisms may be key risk factors for homophobia

A new study that investigated the potential of certain psychological traits for predisposing heterosexuals to have negative attitudes towards homosexual people found that psychoticism-which is present in severe psychopathological conditions but may also contribute to less severe states of hostility and anger-and immature defense mechanisms may be important risk factors for homophobia, while depression and neurotic defense mechanisms appear to lower the risk of being homophobic.

Anavex Life Sciences qualifies to trade on OTCQX

OTC Markets Group Inc., operator of Open, Transparent and Connected financial marketplaces, today announced that Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's disease, other diseases of the central nervous system (CNS), and various types of cancer, has qualified to trade on OTCQX, the best marketplace for established, global and growth companies.

Shield Therapeutics recruits patients for ST10 Phase 3 study for treating iron-deficient anaemia

Shield Therapeutics, the independent specialty mineral medicines pharmaceutical company, today announces that it has completed recruitment of patients into its pivotal Phase 3 programme of ST10 for the treatment of iron-deficient anaemia. ST10 is a novel form of ferric iron taken orally.

Read more Medical News

› Verified 6 days ago